---
title: "Vland Biotech: The company and its subsidiaries jointly applied for the registration certificate of the new veterinary drug for Mianping ointment, which has been approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252634403.md"
description: "Vland Biotech announced that the company and its wholly-owned subsidiaries, Qingdao Vland Zhi Chong Biotechnology Co., Ltd. and Qingdao Kangdian Animal Pharmaceutical Co., Ltd., along with other units, jointly applied for the \"Mirtazapine Ointment\" as a Category V new veterinary drug, and recently received the \"New Veterinary Drug Registration Certificate.\" This product is mainly used to control weight loss in cats, developed jointly by the company and its wholly-owned subsidiaries with multiple units, with a total R&D investment of RMB 1.8622 million. The acquisition of the new veterinary drug certificate is expected to bring new performance growth points to the company's business"
datetime: "2025-08-12T09:03:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252634403.md)
  - [en](https://longbridge.com/en/news/252634403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252634403.md)
---

# Vland Biotech: The company and its subsidiaries jointly applied for the registration certificate of the new veterinary drug for Mianping ointment, which has been approved

Vland Biotech announced that the company and its wholly-owned subsidiaries, Qingdao Vland Zhi Chong Biotechnology Co., Ltd. and Qingdao Kangdi'en Animal Pharmaceutical Co., Ltd., along with other units, jointly applied for "Mirtazapine Ointment" to be classified as a new type of veterinary drug (Category V), and recently received the "New Veterinary Drug Registration Certificate." This product is primarily used to control weight loss in cats and was jointly developed by the company and its wholly-owned subsidiaries in collaboration with multiple units, with a total R&D investment of 1.8622 million yuan. The acquisition of the new veterinary drug certificate is expected to bring new performance growth points to the company's business

### Related Stocks

- [603739.CN](https://longbridge.com/en/quote/603739.CN.md)

## Related News & Research

- [ZAWYA: Al Habtoor Tower: Dubai's boldest residential project yet](https://longbridge.com/en/news/287051508.md)
- [ZAWYA: UAE developers accelerate shift to recurring income amid market uncertainty](https://longbridge.com/en/news/287012545.md)
- [Post Oak Energy Capital Announces Sale of UpCurve Energy Assets](https://longbridge.com/en/news/287062130.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [NRJ Group answers shareholder questions ahead of May 19 AGM](https://longbridge.com/en/news/287103059.md)